[DOI] [PubMed] [Google Scholar] 52.Nitzsche F., Muller C., Lukomska B., Jolkkonen J., Deten A., Boltze J
Programme of Nutrition, Family and Reproductive Health (1998)
E.HuW.PengJ.ZhaoG.NevzorovaY
The TRIUMPH-CVOT readout will not arrive until 2028 or later, but it is the study that ultimately decides whether retatrutide is positioned as a full cardiometabolic compound rather than a weight-loss compound alone
Therefore, it is now timely to conduct a systematic review and meta-analysis to explore the long-term effects of AOMs on body weight after treatment discontinuation, and provide intuitive evidence by means of weight change trajectory
Angiotensin IV itself has been studied more extensively for cognitive effects but is not used clinically